The Symplicity HTN-1, HTN-2 and HTN-3 trials have demonstrated acceptable safety profiles for catheter based<unk><unk> . Patients may experience pain during application of radiofrequency pulses and intraprocedural bradycardia requiring atropine has also been reported. Other documented procedure related complications include femoral artery pseudoaneurysm and<unk>  artery dissection. Of particular concern is the theoretical risk of damage to<unk>  arteries during delivery of radiofrequency energy. An animal study using swine showed no damage to the<unk>  arteries at 6 month follow up. This finding is further supported in human studies in the HTN-1 and HTN-2 trial where follow up imaging has not demonstrated<unk>  vascular damage.
Renal sympathetic denervation
Urinary diversion
Uterus transplantation
Tubuloglomerular feedback
Renal replacement therapy
Diuresis
Ureteroureterostomy
Dopamine therapy